Condition
Fraud
Total Trials
3
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed2
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT02345434Not ApplicableCompleted
The Effect of Informative Letters on the Prescription and Receipt of Schedule II Controlled Substances
NCT03202745Not ApplicableWithdrawn
The Effect of Informative Letters on the Prescription and Receipt of Opioids
NCT02467933Not ApplicableCompleted
The Effect of Informative Letters on the Prescription and Receipt of Seroquel
Showing all 3 trials